348 related articles for article (PubMed ID: 25073477)
1. Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.
Burke MV; Nocjar C; Sonneborn AJ; McCreary AC; Pehek EA
J Neurochem; 2014 Nov; 131(4):432-43. PubMed ID: 25073477
[TBL] [Abstract][Full Text] [Related]
2. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
3. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.
Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
De Deurwaerdère P; Navailles S; Berg KA; Clarke WP; Spampinato U
J Neurosci; 2004 Mar; 24(13):3235-41. PubMed ID: 15056702
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.
Invernizzi RW; Pierucci M; Calcagno E; Di Giovanni G; Di Matteo V; Benigno A; Esposito E
Neuroscience; 2007 Feb; 144(4):1523-35. PubMed ID: 17161544
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
Navailles S; De Deurwaerdère P; Porras G; Spampinato U
Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
[TBL] [Abstract][Full Text] [Related]
7. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
[TBL] [Abstract][Full Text] [Related]
8. Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo.
Navailles S; De Deurwaerdère P; Spampinato U
Biol Psychiatry; 2006 Mar; 59(6):568-75. PubMed ID: 16182256
[TBL] [Abstract][Full Text] [Related]
9. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
Abercrombie ED; DeBoer P
J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
[TBL] [Abstract][Full Text] [Related]
10. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
Di Matteo V; Pierucci M; Esposito E
J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
[TBL] [Abstract][Full Text] [Related]
11. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
12. Serotonin2C receptor stimulation inhibits cocaine-induced Fos expression and DARPP-32 phosphorylation in the rat striatum independently of dopamine outflow.
Devroye C; Cathala A; Maitre M; Piazza PV; Abrous DN; Revest JM; Spampinato U
Neuropharmacology; 2015 Feb; 89():375-81. PubMed ID: 25446572
[TBL] [Abstract][Full Text] [Related]
13. A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT
Lagière M; Bosc M; Whitestone S; Benazzouz A; Chagraoui A; Millan MJ; De Deurwaerdère P
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198169
[TBL] [Abstract][Full Text] [Related]
14. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
[TBL] [Abstract][Full Text] [Related]
15. GABA(A) receptors in the pars compacta and GABA(B) receptors in the pars reticulata of rat substantia nigra modulate the striatal dopamine release.
Balon N; Kriem B; Weiss M; Rostain JC
Neurochem Res; 2002 May; 27(5):373-9. PubMed ID: 12064352
[TBL] [Abstract][Full Text] [Related]
16. Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
Salvatore MF; Gerhardt GA; Dayton RD; Klein RL; Stanford JA
Exp Neurol; 2009 Sep; 219(1):197-207. PubMed ID: 19460370
[TBL] [Abstract][Full Text] [Related]
17. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
Cobb WS; Abercrombie ED
Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
[TBL] [Abstract][Full Text] [Related]
18. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
[TBL] [Abstract][Full Text] [Related]
19. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study.
Di Giovanni G; De Deurwaerdére P; Di Mascio M; Di Matteo V; Esposito E; Spampinato U
Neuroscience; 1999; 91(2):587-97. PubMed ID: 10366016
[TBL] [Abstract][Full Text] [Related]
20. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]